Hidden dUTPase sequence in human immunodeficiency virus type 1 gp120. PMID: 9847382
HIV-1 gp120 and immune network. PMID: 15370273
The alpha helix 1 from the first conserved region of HIV1 gp120 is reconstructed in the short NQ21 peptide. PMID: 29273432
The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development. PMID: 25163695
Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy. PMID: 23278399
The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex. PMID: 26495445
HIV gp120: double lock strategy foils host defences. PMID: 9739096
Mutational pressure makes HIV1 gp120 linear B-cell epitopes shorter and may lead to their disappearance. PMID: 20129670
Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate. PMID: 25915761
Plugging gp120s cavity. PMID: 19000812
Molecular mechanism of HIV-1 gp120 mutations that reduce CD4 binding affinity. PMID: 23297802
Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. PMID: 21345545
Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120. PMID: 31792886
NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation. PMID: 24819826
A modeled structure of an aptamer-gp120 complex provides insight into the mechanism of HIV-1 neutralization. PMID: 20527993
Variability in the Glycosylation Patterns of gp120 Proteins from Different Human Immunodeficiency Virus Type 1 Isolates Expressed in Different Host Cells. PMID: 34448591
The β20-β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions. PMID: 29051495
gp120: Biologic aspects of structural features. PMID: 11244037
Genetic variability of HIV-1. PMID: 8883605
[Structural mechanism of immune evasion of HIV-1 gp120 by genomic, computational, and experimental science]. PMID: 21972555
Allosteric induction of the CD4-bound conformation of HIV-1 Gp120. PMID: 24304511
Structure and Dynamics of the Native HIV-1 Env Trimer. PMID: 25762739
Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41. PMID: 12769725
The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates. PMID: 25188269
A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4. PMID: 28429756
The HIV-1 gp120 major variable regions modulate cold inactivation. PMID: 23345516
Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells. PMID: 20471426
The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry. PMID: 23916815
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist. PMID: 24502450
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. PMID: 11188697
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. PMID: 20080564
Stoichiometric parameters of HIV-1 entry. PMID: 25463598
Insight derived from molecular dynamics simulations into molecular motions, thermodynamics and kinetics of HIV-1 gp120. PMID: 25105502
[Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1]. PMID: 1518160
The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. PMID: 26018158
Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments. PMID: 22117536
Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange. PMID: 20660185
Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. PMID: 15207637
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. PMID: 2187500
Correlated mutations at gp120 positions 322 and 440: implications for gp120 structure. PMID: 18275085
Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions. PMID: 7678271
Nonneutralizing antibodies to the CD4-binding site on the gp120
Development of noninvasive imaging to measure spontaneous pain in mice., PMID:40475419
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines., PMID:40438096
Immunoinformatic-driven design and evaluation of multi-epitope mRNA vaccine targeting HIV-1 gp120., PMID:40433366
Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening., PMID:40382314
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies., PMID:40377318
Convergence and divergence of B cell responses in two HIV-1 Env immunizations in Rhesus macaques., PMID:40374902
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer., PMID:40339576
Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles., PMID:40313367
Neuroinflammation, Blood-Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies., PMID:40285014
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge., PMID:40266065
Comprehensive maps of escape mutations from antibodies 10-1074 and 3BNC117 for Envs from two divergent HIV strains., PMID:40261015
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost., PMID:40215224
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques., PMID:40192306
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns., PMID:40178906
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors., PMID:40161655
A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120., PMID:40145736
Covariation of Amino Acid Substitutions in the HIV-1 Envelope Glycoprotein gp120 and the Antisense Protein ASP Associated with Coreceptor Usage., PMID:40143251
Host factor Naf1 restricts HIV-1 infection of myeloid cells and compromises the capacity of dendritic cell to prime CD4+ T cell., PMID:40139499
The membrane-proximal external region of human immunodeficiency virus (HIV-1) envelope glycoprotein trimers in A18-lipid nanodiscs., PMID:40089599
[Quercetin mitigates HIV-1 gp120-induced rat astrocyte neurotoxicity via promoting G3BP1 disassembly in stress granules]., PMID:40031974
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses., PMID:40006680
HIV-1 gp120 Interactions with Nicotine Modulate Mitochondrial Network Properties and Amyloid Release in Microglia., PMID:39992414
Versatile Features of an Antibody Mimetic Peptide and Its Variants., PMID:39962901
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1., PMID:39956341
NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption., PMID:39953264
Cysteines shape antibody battles for HIV-1 Env., PMID:39947129
Activation of CXCR3+ Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development., PMID:39932316
PET imaging of HIV-1 envelope protein gp120 using 18F-labeled nanobodies., PMID:39917021
Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection., PMID:39912667
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development., PMID:39909038
Covariation of amino acid substitutions in the HIV-1 envelope glycoprotein gp120 and the antisense protein ASP associated with coreceptor usage., PMID:39868319
Monovalent Lectin Microvirin Utilizes Hydropathic Recognition of HIV-1 Env for Inhibition of Virus Cell Infection., PMID:39861871
PKR Inhibitor C16 Regulates HIV-gp120 Induced Neuronal Injury and Cognitive Impairment in Vivo and in Vitro Models., PMID:39752056
p62 Binding to Protein Kinase C Regulates HIV-1 gp120 V3 Loop Induced Microglial Inflammation., PMID:39731677
Two Disaccharide-Bearing Polyethers, K-41B and K-41Bm, Potently Inhibit HIV-1 via Mechanisms Different from That of Their Precursor Polyether, K-41A., PMID:39727933
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies., PMID:39675002
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines., PMID:39671174
Stronger binding affinities of gp120/CD4 in Catarrhini provide insights into HIV/host interactions., PMID:39620069
Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity., PMID:39563795
Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen., PMID:39558498
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation., PMID:39508605
Type-1-to-type-2 transition of brain microvascular pericytes induced by cytokines and disease-associated proteins: Role in neuroinflammation and blood-brain barrier disruption., PMID:39473432
Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells., PMID:39466835
Investigating the Effect of GLU283 Protonation State on the Conformational Heterogeneity of CCR5 by Molecular Dynamics Simulations., PMID:39435878
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity., PMID:39380992
CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies., PMID:39373535
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses., PMID:39339842
Simultaneous Protein and RNA Analysis in Single Extracellular Vesicles, Including Viruses., PMID:39306763
AI-based IsAb2.0 for antibody design., PMID:39285513
Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse., PMID:39272987
For research use only. Not for human or drug use.
